Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Alina, De Rosa"'
Autor:
Alessio Gambardella, Gaetano Licata, Alina De Rosa, Giulia Calabrese, Roberto Alfano, Giuseppe Argenziano
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 1, Pp 52-58 (2023)
Abstract Background Information is lacking from real‐life studies evaluating the efficacy of tildrakizumab in moderate‐to‐severe psoriasis. Materials and Methods We retrospectively analysed a database of 30 patients with moderate‐to‐severe
Externí odkaz:
https://doaj.org/article/7d1735a3694c4f40a60023e66ede5d32
Autor:
Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandro Zullo, Martina Fiocchi, Delia Colombo
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Psoriasis is a chronic immune-mediated inflammatory skin disease which can also involve joints. It is often associated with burdensome comorbidities which negatively impact prognosis and quality of life (QoL). Biologic agents have
Externí odkaz:
https://doaj.org/article/bf7a33c77b234fa2ab263ac7a808782f
Autor:
Dario Buononato, Gaetano Licata, Alessio Gambardella, Alina De Rosa, Giulia Calabrese, Giuseppe Argenziano
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/76b1b35c174048a68e68edfa86806112
Autor:
Giulia Calabrese, Gaetano Licata, Alessio Gambardella, Alina De Rosa, Roberto Alfano, Giuseppe Argenziano
Publikováno v:
Dermatology Practical & Conceptual (2022)
Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional drugs remain a milestone for the treatment of this dermatosis
Externí odkaz:
https://doaj.org/article/9d38213759da4869983011759298d896
Autor:
Alessio Gambardella, Gaetano Licata, Alina De Rosa, Giulia Calabrese, Roberto Alfano, Giuseppe Argenziano
Publikováno v:
JEADV Clinical Practice. 2:52-58
Autor:
Vittorio Tancredi, Gaetano Licata, Giulia Calabrese, Dario Buononato, Alina De Rosa, Giuseppe Argenziano, Alessio Gambardella
Down syndrome (DS) is the most common chromosomal disorder; several dermatological conditions are common in these patients; among them, psoriasis and atopic dermatitis can be frequently encountered. From 2017 to today, we retrospectively identified 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bfa2a55adc2f3c7315f69bfb47a75c3
https://hdl.handle.net/11591/496870
https://hdl.handle.net/11591/496870
Autor:
Giovanni Pellacani, Annamaria Offidani, Aurora Parodi, Alina De Rosa, Martina Burlando, Maria Concetta Fargnoli, Alessandro Zullo, Emanuela Zagni, Federico Bardazzi, Eugenio Provenzano, Chiara Moltrasio, Lucia Simoni, Piergiorgio Malagoli, Delia Colombo, Andrea Conti, Luca Stingeni, Michela Ortoncelli, Giuseppe Argenziano, Salvatore Corrao, Annalisa Tonini, Francesca Gaiani, Katharina Hansel, Marina Talamonti, Matteo Megna, Ketty Peris, Matteo Paolinelli, Rosaria Fidanza, Gabriella Fabbrocini, Clara De Simone, Antonio Costanzo, Marco Adriano Chessa, Luca Bianchi, Alessandra Narcisi, Massimo Raspanti, Paolo Dapavo, Marco Romanelli, C. Carrera, M. Fiocchi, Silvana Ruffolo
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Health Services Research
BMC Health Services Research
BackgroundPsoriasis is a chronic immune-mediated inflammatory skin disease which can also involve joints. It is often associated with burdensome comorbidities which negatively impact prognosis and quality of life (QoL). Biologic agents have been show
Autor:
Gaetano Licata, Vittorio Tancredi, Giulia Calabrese, Dario Buononato, Alina De Rosa, Giuseppe Argenziano, Alessio Gambardella
Publikováno v:
International journal of dermatology.
Autor:
Gaetano Licata, Alina De Rosa, Francesca Pagliuca, Giuseppe Argenziano, Roberto Alfano, Giulia Calabrese, Alessio Gambardella
Publikováno v:
Psoriasis: Targets and Therapy
Psoriasis: Targets and Therapy, Vol Volume 10, Pp 57-60 (2020)
Psoriasis: Targets and Therapy, Vol Volume 10, Pp 57-60 (2020)
Alessio Gambardella,1 Gaetano Licata,1 Giulia Calabrese,1 Alina De Rosa,1 Francesca Pagliuca,2 Roberto Alfano,3 Giuseppe Argenziano1 1Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Van